O	0	10	Comparison
O	11	13	of
B-Diagnostic_tool	14	22	spectral
I-Diagnostic_tool	22	23	-
I-Diagnostic_tool	23	29	domain
I-Diagnostic_tool	30	36	versus
I-Diagnostic_tool	37	41	time
I-Diagnostic_tool	41	42	-
I-Diagnostic_tool	42	48	domain
I-Diagnostic_tool	49	56	optical
I-Diagnostic_tool	57	66	coherence
I-Diagnostic_tool	67	77	tomography
O	78	80	in
O	81	91	management
O	92	94	of
B-Disease	95	98	age
I-Disease	98	99	-
I-Disease	99	106	related
I-Disease	107	114	macular
I-Disease	115	127	degeneration
O	128	132	with
O	133	144	ranibizumab
O	144	145	.

O	147	149	To
O	150	157	compare
O	158	161	the
O	162	169	ability
O	170	172	to
O	173	182	delineate
O	183	186	and
O	187	193	detect
O	194	202	patterns
O	203	205	of
B-Symptom	206	215	choroidal
I-Symptom	216	234	neovascularization
O	235	236	(
B-Symptom	236	239	CNV
O	239	240	)
O	241	249	activity
O	250	252	in
O	253	261	patients
O	262	266	with
B-Disease	267	276	exudative
I-Disease	277	280	age
I-Disease	280	281	-
I-Disease	281	288	related
I-Disease	289	296	macular
I-Disease	297	309	degeneration
O	310	311	(
B-Disease	311	314	AMD
O	314	315	)
O	316	321	after
O	322	333	ranibizumab
O	334	343	treatment
O	344	351	between
B-Diagnostic_tool	352	356	time
I-Diagnostic_tool	356	357	-
I-Diagnostic_tool	357	363	domain
I-Diagnostic_tool	364	371	optical
I-Diagnostic_tool	372	381	coherence
I-Diagnostic_tool	382	392	tomography
O	393	394	(
B-Diagnostic_tool	394	396	TD
I-Diagnostic_tool	396	397	-
I-Diagnostic_tool	397	400	OCT
O	400	401	)
O	402	405	and
O	406	407	4
O	408	417	different
B-Diagnostic_tool	418	426	spectral
I-Diagnostic_tool	426	427	-
I-Diagnostic_tool	427	433	domain
I-Diagnostic_tool	434	441	optical
I-Diagnostic_tool	442	451	coherence
I-Diagnostic_tool	452	462	tomography
O	463	464	(
B-Diagnostic_tool	464	466	SD
I-Diagnostic_tool	466	467	-
I-Diagnostic_tool	467	470	OCT
O	470	471	)
O	472	479	devices
O	479	480	.

O	481	492	Prospective
O	492	493	,
O	494	505	consecutive
O	506	510	case
O	511	517	series
O	517	518	.

O	519	524	Sixty
O	524	525	-
O	525	528	one
B-Anatomy	529	533	eyes
O	534	536	of
O	537	539	58
O	540	548	patients
O	549	553	with
B-Disease	554	563	exudative
I-Disease	564	567	AMD
O	568	573	after
O	574	585	ranibizumab
O	586	595	treatment
O	596	600	were
O	601	609	included
O	610	612	in
O	613	617	this
O	618	623	study
O	623	624	.

O	625	628	All
O	629	637	patients
O	638	642	were
O	643	649	imaged
O	650	654	with
B-Diagnostic_tool	655	657	TD
I-Diagnostic_tool	657	658	-
I-Diagnostic_tool	658	661	OCT
O	662	665	and
O	666	668	at
O	669	674	least
O	675	676	1
O	677	679	of
O	680	681	4
O	682	691	different
B-Diagnostic_tool	692	694	SD
I-Diagnostic_tool	694	695	-
I-Diagnostic_tool	695	698	OCT
O	699	706	devices
O	707	709	at
O	710	713	the
O	714	718	same
O	719	724	visit
O	725	730	after
O	731	742	ranibizumab
O	743	752	treatment
O	752	753	.

O	754	757	The
B-Diagnostic_tool	758	761	OCT
I-Diagnostic_tool	762	768	images
O	769	773	were
O	774	782	analyzed
O	783	785	in
O	786	787	a
O	788	794	masked
O	795	802	fashion
O	803	805	by
O	806	807	2
O	808	819	independent
O	820	827	graders
O	828	829	(
O	829	831	KS
O	831	832	,
O	833	835	TY
O	835	836	)
O	837	839	to
O	840	849	delineate
O	850	853	and
O	854	860	detect
O	861	864	the
O	865	873	presence
O	874	876	of
B-Symptom	877	880	CNV
O	881	889	activity
O	890	897	defined
O	898	900	as
O	901	904	the
O	905	913	presence
O	914	916	of
B-Symptom	917	927	subretinal
I-Symptom	928	933	fluid
O	933	934	,
B-Symptom	935	947	intraretinal
I-Symptom	948	953	cysts
O	953	954	,
B-Symptom	955	967	intraretinal
I-Symptom	968	973	fluid
O	973	974	,
B-Symptom	975	978	sub
I-Symptom	978	979	-
I-Symptom	979	986	retinal
I-Symptom	987	994	pigment
I-Symptom	995	1005	epithelium
I-Symptom	1006	1007	(
I-Symptom	1007	1010	sub
I-Symptom	1010	1011	-
I-Symptom	1011	1014	RPE
I-Symptom	1014	1015	)
I-Symptom	1016	1021	fluid
O	1021	1022	,
O	1023	1025	or
O	1026	1027	a
O	1028	1039	combination
O	1040	1047	thereof
O	1047	1048	.

O	1049	1052	The
O	1053	1062	automated
O	1063	1073	evaluation
O	1074	1076	of
B-Characteristic	1077	1084	retinal
I-Characteristic	1085	1094	thickness
O	1095	1099	also
O	1100	1103	was
O	1104	1112	analyzed
O	1113	1120	between
O	1121	1128	devices
O	1128	1129	.

O	1130	1138	Evidence
O	1139	1141	of
B-Symptom	1142	1145	CNV
O	1146	1154	activity
O	1155	1157	on
O	1158	1164	linear
O	1165	1166	B
O	1166	1167	-
O	1167	1172	scans
O	1173	1176	and
O	1177	1178	3
O	1178	1179	-
O	1179	1190	dimensional
O	1191	1193	so
O	1193	1194	-
O	1194	1200	called
O	1201	1205	cube
O	1206	1211	scans
O	1212	1214	on
B-Diagnostic_tool	1215	1217	SD
I-Diagnostic_tool	1217	1218	-
I-Diagnostic_tool	1218	1221	OCT
O	1222	1225	and
O	1226	1232	linear
O	1233	1234	B
O	1234	1235	-
O	1235	1239	scan
O	1240	1242	on
B-Diagnostic_tool	1243	1245	TD
I-Diagnostic_tool	1245	1246	-
I-Diagnostic_tool	1246	1249	OCT
O	1249	1250	.

O	1251	1253	In
O	1254	1260	linear
O	1261	1262	B
O	1262	1263	-
O	1263	1267	scan
O	1268	1272	mode
O	1272	1273	,
O	1274	1277	all
O	1278	1279	4
B-Diagnostic_tool	1280	1282	SD
I-Diagnostic_tool	1282	1283	-
I-Diagnostic_tool	1283	1286	OCT
O	1287	1294	devices
O	1295	1299	were
O	1300	1308	superior
O	1309	1311	in
O	1312	1317	their
O	1318	1325	ability
O	1326	1328	to
O	1329	1338	delineate
B-Symptom	1339	1342	sub
I-Symptom	1342	1343	-
I-Symptom	1343	1346	RPE
I-Symptom	1347	1352	fluid
O	1353	1361	compared
O	1362	1366	with
B-Diagnostic_tool	1367	1369	TD
I-Diagnostic_tool	1369	1370	-
I-Diagnostic_tool	1370	1373	OCT
O	1374	1375	(
O	1375	1376	P
O	1377	1378	<
O	1379	1380	0
O	1380	1381	.
O	1381	1383	05
O	1383	1384	)
O	1384	1385	.

O	1386	1391	Three
O	1392	1394	of
O	1395	1396	4
B-Diagnostic_tool	1397	1399	SD
I-Diagnostic_tool	1399	1400	-
I-Diagnostic_tool	1400	1403	OCT
O	1404	1411	devices
O	1412	1416	were
O	1417	1425	superior
O	1426	1428	in
O	1429	1440	delineating
B-Symptom	1441	1453	intraretinal
I-Symptom	1454	1459	fluid
O	1459	1460	,
O	1461	1464	and
O	1465	1466	2
O	1467	1469	of
O	1470	1471	4
B-Diagnostic_tool	1472	1474	SD
I-Diagnostic_tool	1474	1475	-
I-Diagnostic_tool	1475	1478	OCT
O	1479	1486	devices
O	1487	1491	were
O	1492	1500	superior
O	1501	1503	in
O	1504	1515	delineating
B-Symptom	1516	1526	subretinal
I-Symptom	1527	1532	fluid
O	1533	1536	and
B-Symptom	1537	1549	intraretinal
I-Symptom	1550	1555	cysts
O	1556	1557	(
O	1557	1558	P
O	1559	1560	<
O	1561	1562	0
O	1562	1563	.
O	1563	1565	05
O	1565	1566	)
O	1566	1567	.

O	1568	1570	In
O	1571	1574	the
O	1575	1576	3
O	1576	1577	-
O	1577	1588	dimensional
O	1589	1591	so
O	1591	1592	-
O	1592	1598	called
O	1599	1603	cube
O	1604	1608	mode
O	1608	1609	,
O	1610	1613	all
O	1614	1615	4
B-Diagnostic_tool	1616	1618	SD
I-Diagnostic_tool	1618	1619	-
I-Diagnostic_tool	1619	1622	OCT
O	1623	1630	devices
O	1631	1635	were
O	1636	1644	superior
O	1645	1647	in
O	1648	1657	detecting
B-Symptom	1658	1668	subretinal
I-Symptom	1669	1674	fluid
O	1675	1678	and
O	1679	1680	2
O	1681	1683	of
O	1684	1685	4
B-Diagnostic_tool	1686	1688	SD
I-Diagnostic_tool	1688	1689	-
I-Diagnostic_tool	1689	1692	OCT
O	1693	1700	devices
O	1701	1705	were
O	1706	1714	superior
O	1715	1717	in
O	1718	1727	detecting
B-Symptom	1728	1731	sub
I-Symptom	1731	1732	-
I-Symptom	1732	1735	RPE
I-Symptom	1736	1739	and
I-Symptom	1740	1752	intraretinal
I-Symptom	1753	1758	fluid
O	1759	1760	(
O	1760	1761	P
O	1762	1763	<
O	1764	1765	0
O	1765	1766	.
O	1766	1768	05
O	1768	1769	)
O	1769	1770	.

O	1771	1776	There
O	1777	1781	were
O	1782	1793	significant
O	1794	1806	correlations
O	1807	1809	in
B-Characteristic	1810	1816	center
I-Characteristic	1817	1822	point
I-Characteristic	1823	1832	thickness
O	1833	1840	between
O	1841	1844	all
B-Diagnostic_tool	1845	1847	SD
I-Diagnostic_tool	1847	1848	-
I-Diagnostic_tool	1848	1851	OCT
O	1852	1859	devices
O	1860	1863	and
B-Diagnostic_tool	1864	1866	TD
I-Diagnostic_tool	1866	1867	-
I-Diagnostic_tool	1867	1870	OCT
O	1871	1872	(
O	1872	1873	P
O	1874	1875	<
O	1876	1877	0
O	1877	1878	.
O	1878	1880	01
O	1880	1881	)
O	1881	1882	,
O	1883	1886	and
O	1887	1888	3
O	1889	1891	of
O	1892	1893	4
O	1894	1897	and
O	1898	1899	1
O	1900	1902	of
O	1903	1904	3
B-Diagnostic_tool	1905	1907	SD
I-Diagnostic_tool	1907	1908	-
I-Diagnostic_tool	1908	1911	OCT
O	1912	1919	devices
O	1920	1926	showed
O	1927	1938	significant
O	1939	1950	differences
O	1951	1955	from
B-Diagnostic_tool	1956	1958	TD
I-Diagnostic_tool	1958	1959	-
I-Diagnostic_tool	1959	1962	OCT
O	1963	1965	in
B-Characteristic	1966	1972	center
I-Characteristic	1973	1978	point
I-Characteristic	1979	1988	thickness
O	1989	1990	(
O	1990	1991	P
O	1992	1993	<
O	1994	1995	0
O	1995	1996	.
O	1996	1998	01
O	1998	1999	)
O	2000	2003	and
B-Characteristic	2004	2010	center
I-Characteristic	2011	2019	subfield
I-Characteristic	2020	2029	thickness
O	2030	2031	(
O	2031	2032	P
O	2033	2034	<
O	2035	2036	0
O	2036	2037	.
O	2037	2040	001
O	2040	2041	)
O	2041	2042	,
O	2043	2055	respectively
O	2055	2056	.

B-Diagnostic_tool	2057	2059	SD
I-Diagnostic_tool	2059	2060	-
I-Diagnostic_tool	2060	2063	OCT
O	2064	2066	is
O	2067	2075	superior
O	2076	2078	to
B-Diagnostic_tool	2079	2081	TD
I-Diagnostic_tool	2081	2082	-
I-Diagnostic_tool	2082	2085	OCT
O	2086	2088	in
O	2089	2099	evaluating
O	2100	2103	for
B-Symptom	2104	2107	CNV
O	2108	2116	activity
O	2117	2119	in
O	2120	2128	patients
O	2129	2133	with
B-Disease	2134	2137	wet
I-Disease	2138	2141	AMD
O	2142	2147	after
O	2148	2159	ranibizumab
O	2160	2169	injection
O	2169	2170	.

B-Characteristic	2171	2178	Retinal
I-Characteristic	2179	2188	thickness
O	2189	2201	measurements
O	2202	2209	between
B-Diagnostic_tool	2210	2212	SD
I-Diagnostic_tool	2212	2213	-
I-Diagnostic_tool	2213	2216	OCT
O	2217	2220	and
B-Diagnostic_tool	2221	2223	TD
I-Diagnostic_tool	2223	2224	-
I-Diagnostic_tool	2224	2227	OCT
O	2228	2232	also
O	2233	2237	were
O	2238	2251	significantly
O	2252	2261	different
O	2261	2262	.

O	2263	2274	Proprietary
O	2275	2277	or
O	2278	2288	commercial
O	2289	2299	disclosure
O	2300	2303	may
O	2304	2306	be
O	2307	2312	found
O	2313	2318	after
O	2319	2322	the
O	2323	2333	references
O	2333	2334	.
